Low-molecular-weight heparins and cancer: Focus on antitumoral effect
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-molecular-weight heparins and cancer: Focus on antitumoral effect
Authors
Keywords
-
Journal
ANNALS OF MEDICINE
Volume 47, Issue 2, Pages 116-121
Publisher
Informa UK Limited
Online
2015-03-13
DOI
10.3109/07853890.2015.1004361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
- (2014) C. E. Chee et al. BLOOD
- The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials
- (2014) D. Sanford et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Heparins and cancer survival: where do we stand?
- (2014) Simon Noble THROMBOSIS RESEARCH
- Cancer related venous thromboembolism - prophylaxis and therapy
- (2014) Thomas Gary Vasa-European Journal of Vascular Medicine
- Treatment of cancer-associated thrombosis
- (2013) A. Y. Y. Lee et al. BLOOD
- Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer
- (2013) Gabriel Rada et al. BMC CANCER
- Anticoagulation for prevention and treatment of cancer-related venous thromboembolism
- (2013) Sarah J. Barsam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells
- (2013) Akihiko Takeuchi et al. CANCER SCIENCE
- The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis
- (2013) D.H. Che et al. European Journal of Internal Medicine
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2013) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: An update of the evidence
- (2013) Grace Townshend et al. THROMBOSIS AND HAEMOSTASIS
- Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study
- (2013) R. Lecumberri et al. THROMBOSIS RESEARCH
- Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer
- (2012) Sylvia K. Haas et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2012) D. FARGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombin and Cancer: From Molecular Basis to Therapeutic Implications
- (2012) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
- (2011) A. Maraveyas et al. EUROPEAN JOURNAL OF CANCER
- Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
- (2011) Frederiek F. van Doormaal et al. JOURNAL OF CLINICAL ONCOLOGY
- PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
- (2010) J. R. PERRY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
- (2009) Gareth O Griffiths et al. BMC CANCER
- Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
- (2009) Giancarlo Agnelli et al. LANCET ONCOLOGY
- The Bidirectional Relationship of Cancer and Hemostasis and the Potential Role of Anticoagulant Therapy in Moderating Thrombosis and Cancer Spread
- (2009) Massimo Franchini et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Does antithrombotic therapy improve survival in cancer patients?
- (2008) Moya S. Cunningham et al. BLOOD REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started